Trial Details
ACTIVE_NOT_RECRUITINGBasic Information
| Clinical ID | c131 |
|---|---|
| Identifier | NCT07123350 |
| Trial Title | Evaluating the Shift From Intravenous to Subcutaneous Vedolizumab for Inflammatory Bowel Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Inflammatory Bowel Disease (IBD)|Crohn&Amp;#39;s Disease (CD)|Ulcerative Colitis (UC) |
| Interventions | DRUG: Patient switched from IV vedolizumab to subcutaneous vedolizumab as part of normal patient care |
Participant Information
| Sponsor | Vanderbilt University Medical Center |
|---|---|
| City | Nashville |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | NULL |
Time Information
| Start Date | 2025-10-16 |
|---|---|
| Primary Completion Date | 2026-03-31 |
| Completion Date | 2026-03-31 |